共 50 条
- [7] The dapagliflozin and prevention of adverse outcomes in chronic kidney disease: results of the DAPA-CKD study [J]. TERAPEVTICHESKII ARKHIV, 2021, 93 (06): : 713 - 723
- [10] Risk improvement and adverse kidney outcomes in patients with chronic kidney disease: findings from KNOW-CKD [J]. Journal of Nephrology, 2023, 36 : 767 - 776